CHEYENNE STOCKTON: Open Payments
NPI 1871321885 · GLASGOW, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$926 in 53 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $110 · 2025 $926
Food & beverage: $926
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $197 |
| Amgen Inc. | 9 | $143 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $104 |
| Viatris Specialty LLC | 5 | $91 |
| Lilly USA, LLC | 3 | $61 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| Phathom Pharmaceuticals, Inc. | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| GlaxoSmithKline, LLC. | 2 | $36 |
Products named: JARDIANCE, Kerendia, OTEZLA, YUPELRI, MOUNJARO, Auvelity, LEQVIO, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
